FDA Guidance Needed for PGx-Based Dosing Dxs Before MDs Will Adopt Them | GenomeWeb
NEW YORK (GenomeWeb News) — The US Food and Drug Administration must issue guidelines to help physicians use pharmacogenomic-backed dosing diagnostics before the clinical community can adopt them fully, a draft HHS report has concluded.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.